Gender-wise distribution of blood biomarkers in patients with COVID-19
| Biomarkers | Male N (mean±SD) | Female (N, mean±SD) | 95% CI | P value | |
| Lower | Upper | ||||
| RBC (million counts per μL) | 98 (3.91±0.95) | 46 (3.69±0.78) | −0.10 | 0.54 | 0.176 |
| HB (g/L) | 98 (111±2.52) | 46 (100.1±1.79) | 0.27 | 1.91 | <0.009** |
| HCT (%) | 98 (32.54±7.57) | 46 (30.24±5.39) | −0.15 | 4.76 | 0.066 |
| CRP (mg/L) | 467 (152.59±101.62) | 236 (120.21±103.42) | 16.36 | 48.41 | <0.001** |
| WBC (μL) | 98 (15 389.18±16 779.11) | 46 (15 312.83±11 454.40) | −5327.04 | 5479.75 | 0.978 |
| AST (U/L) | 56 (75.70±78.47) | 18 (52.33±32.34) | −14.64 | 61.37 | 0.224 |
| ALT (U/L) | 59 (83.14±95.32) | 20 (58.90±63.68) | −21.40 | 69.87 | 0.294 |
| LDH (U/L) | 125 (491.36±206.32) | 63 (449.40±196.39) | −19.93 | 103.86 | 0.183 |
**P<0.01.
ALT, alanine transaminase; AST, aspartate aminotransferase; HB, haemoglobin; HCT, haematocrit ; LDH, lactate dehydrogenase; p, probability; RBC, red blood cell; WBC, white blood cell.